Davis, Kevin C.
Meschede-Krasa, Benyamin
Cajigas, Iahn
Prins, Noeline W.
Alver, Charles
Gallo, Sebastian
Bhatia, Shovan
Abel, John H.
Naeem, Jasim A.
Fisher, Letitia
Raza, Fouzia
Rifai, Wesley R.
Morrison, Matthew
Ivan, Michael E.
Brown, Emery N.
Jagid, Jonathan R.
Prasad, Abhishek http://orcid.org/0000-0001-9586-9400
Clinical trials referenced in this document:
Documents that mention this clinical trial
Design-development of an at-home modular brain–computer interface (BCI) platform in a case study of cervical spinal cord injury
https://doi.org/10.1186/s12984-022-01026-2
Funding for this research was provided by:
The Miami Project to Cure Paralysis
Article History
Received: 16 May 2021
Accepted: 13 May 2022
First Online: 3 June 2022
Declarations
:
: All study procedures were approved by the University of Miami Institutional Review Board and the U.S. FDA ClinicalTrials.gov: NCT02564419. The registration for the trail was first submitted to ClinicalTrials.gov on 08/18/2015 and first posted on 09/30/2015 after meeting the QC criteria. The study subject signed the consent on 11/02/2018.
: Not applicable.
: JJ reports support from Medtronic Inc, during the conduct of the study; grants and personal fees from Medtronic Inc, grants from Boston Scientific, outside the submitted work. Outside the submitted work, EB is a cofounder of PASCALL, a company developing closed-loop physiological control systems and a cofounder of Neuradia, a company developing agents to promote recovery of consciousness following general anesthesia or sedation. In addition, EB has a patent SYSTEMS AND METHODS FOR ANALYZING ELECTROPHYSIOLOGICAL DATA FROM PATIENTS UNDERGOING MEDICAL TREATMENTS. MI reports personal fees from Medtronic—Visualase outside the submitted work.